Skip to contentB
Biomerica Inc
B
BMRABiomerica Inc Q1 2025 · 10-Q
Revenue$1.81M$1.81M+5.5% vs Q1 2024 Net Income-$1.32M-$1.32MN/M vs Q1 2024 EPS Diluted-$0.63-$0.63N/M vs Q1 2024 Gross Profit$289,000−29.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biomerica Inc · CIK 73290 · Engraved from SEC EDGAR
Operating Cash Flow-$1,344,000N/M Margins · derivedGross margin16.0%−8.1 pt vs Q1 2024
Operating margin-75.7%−3.8 pt vs Q1 2024
Net margin-72.8%−6.7 pt vs Q1 2024
ended Aug 31, 2024 · filed Oct 15, 2024 · 45 d after period end